Showing results (221-230 of 231) with videos related to

Sort By:
Pageof 24
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 11, 2003
Effect of poly(ADP ribose) synthetase inhibition on burn and smoke inhalation injury in sheepKatsumi Shimoda, Kazunori Murakami, Perenlei Enkhbaatar, et al.
Molecular Cancer Therapeutics|September 20, 2005
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograftC Lynn Cheng, Stewart P Johnson, Stephen T Keir, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 5, 2002
Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymeraseJ G Mabley, P Jagtap, M Perretti, et al.
International Journal of Molecular Medicine|June 9, 2005
Antibodies raised against N'-terminal Pseudomonas aeruginosa flagellin prevent mortality in lethal murine models of infectionLewis F Neville, Yoav Barnea, Orly Hammer-Munz, et al.
Shock (Augusta, Ga.)|June 26, 2010
The peroxynitrite catalyst WW-85 improves pulmonary function in ovine septic shockDirk M Maybauer, Marc O Maybauer, Csaba Szabó, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|March 5, 2019
Utility of Magnetic Resonance Imaging Features for Improving the Diagnosis of Idiopathic Intracranial Hypertension Without PapilledemaRobert M Mallery, Obeidurahman F Rehmani, John H Woo, et al.
Shock (Augusta, Ga.)|January 31, 2004
Inhibition of poly (ADP-ribose) polymerase attenuates acute lung injury in an ovine model of sepsisKazunori Murakami, Perenlei Enkhbaatar, Katsumi Shimoda, et al.
Critical Care Medicine|May 15, 2002
Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agentsPrakash Jagtap, Francisco Garcia Soriano, László Virág, et al.
British Journal of Pharmacology|February 19, 2017
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseasesNathan A Berger, Valerie C Besson, A Hamid Boulares, et al.
Neuro-Oncology Advances|December 30, 2024
Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastomaJoe S Mendez, Adam L Cohen, Midori Eckenstein, et al.
Pageof 24